An Open, Single Dose, Phase I Study of the Excretion of Radioactivity, Metabolism and Pharmacokinetics Following Oral Administration of [14C]AZD1386 to Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 1386 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 29 Apr 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 29 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2009 New trial record